Impact of serological and PCR testing requirements on the selection of COVID‐19 convalescent plasma donors von Carter, Jason A., Freedenberg, Alex T., Romeiser, Jamie L., Talbot, Lillian R., Browne, Nicholas J., Cosgrove, Megan E., Shevik, Margaret E., Generale, Laura M., Rago, Molly G., Caravella, Giuseppina A., Ahmed, Tahmeena, Mamone, Linda J., Bennett‐Guerrero, Elliott

Volltext

Adjuvant FOLFOX-Nab-paclitaxel (FOLFOX-A) for pancreatic cancer: A phase II Brown University Oncology Research Group (BrUOG) trial von Safran, Howard, Charpentier, Kevin, Mantripragada, Kalyan C., Breakstone, Rimini, Miner, Thomas J., DiPetrillo, Thomas A., Marks, Eric I, Rosati, Kayla, Mitchell, Kristen, Rossiter, Rachael, Luppe, Denise, Rago, Molly, Schumacher, Andrew, Cavanagh, Lindsey

Volltext

Comparable outcomes in CLL patients treated with reduced-dose ibrutinib: Results from a multi-center study von Timlin, Colleen, Banerjee, Rahul, Howlett, Christina, Ujjani, Chaitra Shankar, Skarbnik, Alan P., Fanning, Molly, Schuster, Stephen J., Svoboda, Jakub, Porter, David L., Nasta, Sunita, Stadtmauer, Edward A., Landsburg, Daniel Jeffrey, Feldman, Tatyana, Rago, Allison, Dorsey, Colleen, Capozzi, Donna L., Morganroth, Jennifer, Goy, Andre, Cheson, Bruce D., Mato, Anthony R.

Volltext